We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAGN:NYSEMagnera Corporation analysis

Data as of Oct 8, 2026 - not real-time

Latest price
$11.66
Risk: high
9/10High risk

Summary

The moving-average structure behind Magnera Corporation is neutral at $11.66, with no clear ordering between short and long averages. The last 30 days have lost 8.5%. With RSI at 45.8 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $11.09 and resistance around $12.33.
Multiples put this in undervalued territory at a P/E of 7.2. Consensus targets land 32.9% above where the shares trade now. Revenue is growing at 2.1% on a -3.4% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 30.9%, a beta of 1.22 and a maximum drawdown of 41.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.

Top market events

  • Merger synergies and Project CORE savings offset raw material inflation pressures.
  • Merger synergies and Project CORE savings offset raw material inflation pressures.
  • Read Magnera Corporation MAGN Q3 FY2026 earnings call transcript on Yahoo Finance to keep your investing strategy up to...

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading below the 200-day average of 12.20
  • MACD momentum is positive
  • 30-day price change of -8.5%

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading below the 200-day average of 12.20
  • Analyst targets imply +32.9% versus the current price
  • MACD momentum is positive

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Negative profit margin of -3.4%
  • Analyst targets imply +32.9% versus the current price
  • Negative return on equity of -10.4%

Key metrics

Financial health

Revenue Growth2.10%
Profit Margin-3.41%
P/E Ratio7.2
ROE-10.43%
ROA2.27%
Debt/Equity192.82
P/B Ratio0.4
Op. Cash Flow$172.0M
Free Cash Flow$230.0M

Technical analysis

TrendNeutral
RSI45.8
Support$11.09
Resistance$12.33
MA 20$11.69
MA 50$12.24
MA 200$12.20
MACDBullish
VolumeStable
Fear & Greed Index94.5

Valuation

Fair Value$36.32
Target Price$15.50
Upside/Downside32.93%
GradeUndervalued
TypeValue

Risk assessment

Beta1.22
Volatility30.86%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.